ProCE Banner Activity

Incorporating Immune Checkpoint Inhibitors Into Practice for Advanced Urothelial Cancer: Expert Perspectives from Argentina in Spanish (Podcast Pearls)

PDF
Experts from Argentina provide their thoughts on recent advances with immune checkpoint therapy for advanced urothelial carcinoma.

Released: March 01, 2021

Expiration: February 28, 2022

No longer available for credit.

Share

Faculty

Alejandro Nolazco

Alejandro Nolazco, MD

Associate Professor
Department of Urology
Universidad Austral and Universidad Católica Argentina
Buenos Aires, Argentina

José Ignacio Nolazco

José Ignacio Nolazco, MD

Urology Fellow
Hospital Universitario Austral
Buenos Aires, Argentina

Supporters

Supported by an educational grant from

Pfizer and EMD Serono

Faculty Disclosure

Primary Author

Alejandro Nolazco, MD

Associate Professor
Department of Urology
Universidad Austral and Universidad Católica Argentina
Buenos Aires, Argentina

José Ignacio Nolazco, MD

Urology Fellow
Hospital Universitario Austral
Buenos Aires, Argentina